Prof Karl Claxton from the University of York believes this to be the case https://lnkd.in/dHrZSty
News
Prof Karl Claxton from the University of York believes this to be the case https://lnkd.in/dHrZSty
We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...
Read moreOur experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch